Editor:

As the prevalence of coronavirus disease 2019 (COVID-19) infection continues to rise, there is increased risk of disease transmission to health care workers performing procedures where the virus may aerosolize, such as computed tomography (CT)--guided transthoracic lung biopsy. We report a case of an asymptomatic patient in whom COVID-19 infection was diagnosed based on imaging findings at the time of CT-guided transthoracic lung biopsy. Institutional review board approval was not required for this case report.

A 61-year-old asymptomatic man with prior tonsillar cancer was referred for CT-guided transthoracic lung biopsy of a suspicious nodule identified on chest CT 1 month prior ([Fig 1](#fig1){ref-type="fig"} ). Laboratory testing performed before the biopsy demonstrated a mildly decreased white blood cell count of 3,100/mm^2^ (normal range, 4,000--11,000/mm^2^), with otherwise normal laboratory values. CT performed in the prone position before the procedure redemonstrated the suspicious left lower lobe nodule as well as multiple new ground-glass and nodular opacities in the periphery of both lungs ([Fig 2a--c](#fig2){ref-type="fig"} ). The imaging findings raised concern for possible asymptomatic COVID-19 infection, and the lung biopsy was postponed. The patient was subsequently referred for polymerase chain reaction testing, which confirmed COVID-19 infection.Figure 1Noncontrast chest CT image obtained 1 month before transthoracic lung biopsy demonstrating a suspicious 1.1 × 1.5 cm nodule left lower lobe (white arrow). No other lung abnormalities were present.Figure 2CT images obtained in the prone position before CT-guided transthoracic lung biopsy, from cranial to caudal **(a--c)**. There are multiple new ground-glass opacities in the lung periphery, some with a rounded morphology (blue arrows). The suspicious left lower lobe nodule persists (white arrow).

Up to 50% of patients infected with COVID-19 are either asymptomatic or capable of disease transmission before showing symptoms ([@bib1]). A recent study of patients with polymerase chain reaction--proven COVID-19 found that 54% of the asymptomatic cohort had lung opacities present on CT ([@bib2]). The most commonly reported chest CT findings of COVID-19 infection include peripheral predominant ground-glass opacities and consolidations, sometimes with a rounded morphology ([@bib3]). Although COVID-19 infection is transmitted primarily through direct contact or respiratory droplets, patients with a cough can aerosolize the virus. Because many of the complications from CT-guided transthoracic lung biopsy are likely to induce coughing ([@bib4]), there is increased risk of disease transmission to health care workers who may be using only standard universal precautions during the procedure.

With widespread community transmission of COVID-19 in many parts of the United States, interventional radiologists performing CT-guided transthoracic procedures should carefully review imaging obtained before procedures for findings associated with COVID-19 infection, including in asymptomatic patients. Depending on the clinical setting, it may be prudent to either defer the interventional procedure and obtain COVID-19 testing or use more stringent airborne precautions to avoid accidental exposure to the COVID-19 virus.
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